@entity6583 in XXXX : clinical characteristics and outcome.

@entity1 @entity3753 @entity6583 @entity410 @entity75 @entity4 @entity302
A study was undertaken on 176 @entity1 with @entity6583 to determine the clinical behaviour and long-term outcome of cases. The @entity1 were followed up prospectively in the paediatric neurology clinic for 6 years. Diagnosis was based primarily on CT scans. All the CT lesions were parenchymal and mostly single (87%) with ring enhancement and peri-lesional @entity4 . Partial @entity410 was the predominant presenting @entity410 type. About 65% of cases had recurrences at varying intervals during treatment. Albendazole therapy given to some cases did not appear to have any beneficial effect on @entity410 control. Repeat CTs done at varying intervals after the first @entity410 showed disappearance of the lesions in about 50% of cases. The majority of lesions disappeared without the use of @entity3753 . Recurrence of @entity410 after withdrawal of anti- @entity302 medication was observed in 19% of the cases. @entity6583 in @entity1 commonly presents with partial @entity410 and @entity75 on CT. The disease can be managed well by anti- @entity302 medication alone and the prognosis is good.
